Dr. David Pearlstone from DICOM Director reveals how next‑gen CT imaging, AI, and 3D workflows are converging into a spatial computing ecosystem that’s reshaping the future of healthcare.
#MedTech#3DPrinting#Surgery#Medicine
Dr. Beatriz Dominguez Gonzalez from Materialise breaks down the AMA’s new Category III CPT codes for digital 3D workflows. #MedTech#HealthTech
Watch the full webinar on our website.
Attended the @MaterialiseNV "3D Planning and Printing in Hospitals 2026 Forum" in Europe + sat down with CEO Brigitte de Vet-Veithen for a 40-min deep dive on #TheLattice Podcast.🧵
We covered: → Growth & acquisition strategy → Tech evolution in hospital 3D printing → Real barriers to personalized medicine at scale
🔗 Full episode +show notes:
https://t.co/yAZuzl5bl0
#3DPrinting #MedTech #HealthTech #Materialise #Podcast #AI #Robotics #Personalizedmedicine
Excited to be presenting at the F50 Physical AI Summit next Wednesday in Silicon Valley.
I'll be joining a group of founders and investors for a spotlight on breakout physical AI companies.
🚀 MM-Hand 1.0 Tech Report released: a 21-DoF multi-modal modular dexterous robotic hand with remote tendon-driven actuation.
Motors are relocated outside the hand, freeing space for tactile sensors, joint encoders, in-palm stereo vision, and maintainable modular fingers.
MM-Hand achieves 25N fingertip force through 1m tendon-sheath transmission and supports closed-loop joint control for dexterous manipulation research.
Paper: https://t.co/K7L7BaW8uS
Page: https://t.co/8QpHEZeTQi
#Robotics #DexterousHand #EmbodiedAI
Can a #robot’s shape influence how it senses, thinks and moves?
Find out in this episode of @RobotTalkPod with @MorningChenying (@UniofOxford), exploring how a robot’s physical form contributes to processing, decision-making and movement.
🎧Listen here: https://t.co/gMXlATBPG0
MIT engineers have developed “mini livers” that could be injected into the body and take over the functions of the failing liver. This would help patients who are on a waitlist for a liver transplant or those who aren’t healthy enough to tolerate surgery.
https://t.co/B6odCTawl0
Just released: ARM's Q1 2026 Cell & Gene Therapy Sector Snapshot! 🧬 📊
Check out this year's CGT trends, including the latest clinical pipeline, regulatory developments, commercial outlook, and company raises.
Access the report here: https://t.co/7UPe0JlO2b